HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


High Proportion Of Supplements Sold Online In France Making Unlawful Claims

Executive Summary

An investigation by the French General Directorate for Competition Policy, Consumer Affairs and Fraud Control found more than half of firms selling dietary supplements online were making unauthorized claims for their products.

You may also be interested in...

French Authority Asks For More Data On Turmeric Supplements After Hepatitis Cases Reported

Following reports of side-effects linked to turmeric supplement use in France and Italy, the former's Agency for Food, Environmental and Occupational Health & Safety (ANSES) is asking manufacturers selling turmeric supplements in the country to provide additional bioavailability data. ANSES is concerned that new formulations are pushing consumers over the recommended daily intake limit set by the European Food Safety Authority. 

Government Skepticism And Over Regulation Holding Back Self-Care In France – GSCF Analysis

France's self-medication market lags behind its European rivals. Why is that? A skeptical and over-cautious government and a stifling regulatory system may provide at least part of the answer, the Global Self-Care Federation's recently published Self-Care Readiness Index suggests.  

Ginger, Mushroom, Aloe Supplements Get US FDA Warnings For Disease Claims

Three firms were warned after FDA inspectors reviewed their websites or social media posts. No facility inspections nor warnings about GMP problems were noted in the letters.


Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts